![Gary Jacob](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gary Jacob
Direktor/Vorstandsmitglied bei
ACTAVIA LIFE SCIENCES, INC.
Vermögen: 188 866 $ am 31.07.2026
Profil
Gary S.
Jacob is the founder of Synergy Pharmaceuticals, Inc., founded in 2008.
Titles held include Chairman, President & Chief Executive Officer from 2013 to 2017.
Dr. Jacob is also the founder of Synergy Pharmaceuticals LLC.
Current jobs include Chief Development Officer & Executive Director at OKYO Pharma Ltd. starting in 2026, and Independent Director at Actavia Life Sciences, Inc. starting in 2020.
Former jobs include President, Chief Executive Officer & Director at Callisto Pharmaceuticals, Inc. from 2004 to 2013; President, Chief Executive Officer & Director at Pawfect Foods, Inc. in 2008; CEO, Non-Executive Director & Managing Director at Immuron Ltd. from 2019 to 2020; Chairman at Hepion Pharmaceuticals, Inc. from 2014 to 2024; Chairman at Synergy DE in 2008; Director-Functional Genomics, Science & Technology at Monsanto Co. from 1997 to 1998; Independent Director at Cardiff Oncology, Inc. from 2012 to 2021; Glycobiology Director at G.D.
Searle LLC from 1990 to 1997; Independent Director at Virpax Pharmaceuticals, Inc. from 2020 to 2022; Manager-Searle Glycobiology Group at the University of Oxford in 1990.
Education includes a doctorate from the University of Wisconsin and undergraduate degree from the University of Missouri-St. Louis.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
OKYO PHARMA LIMITED 0,22 % | 22.07.2026 | 112 420 ( 0,22 % ) | 188 866 $ | 31.07.2026 |
Aktive Positionen von Gary Jacob
| Unternehmen | Position | Beginn |
|---|---|---|
| ACTAVIA LIFE SCIENCES, INC. | Direktor/Vorstandsmitglied | 23.12.2020 |
| WEST AFRICAN MINERALS CORP | Direktor/Vorstandsmitglied | 07.01.2021 |
Ehemalige bekannte Positionen von Gary Jacob
| Unternehmen | Position | Ende |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 19.03.2014 |
| VIRPAX PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 25.07.2022 |
| IMMURON LIMITED | Vorstandsvorsitzender | 25.03.2020 |
| SYNERGY PHARMACEUTICALS INC | Vorstandsvorsitzender | 19.12.2017 |
Synergy Pharmaceuticals, Inc. /Old/
 Synergy Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Researches and develops drugs to treat hepatitis C, hepatitis B, epilepsy and brain cancer | Vorstandsvorsitzender | 01.10.2017 |
Ausbildung von Gary Jacob
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
80
Beziehungen ersten Grades
16
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
Monsanto Co.
 Monsanto Co. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company controlling insects and weeds & manufactures seeds and genomics | Commercial Services |
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops novel therapeutics to treat cancer | Health Technology |
Pawfect Foods, Inc.
 Pawfect Foods, Inc. Specialty StoresRetail Trade Sells pet food via the internet | Retail Trade |
OKYO Pharma Ltd.
 OKYO Pharma Ltd. BiotechnologyHealth Technology Develops next-generation therapeutics to improve the lives of patients suffering from inflammatory eye diseases | Health Technology |
Hepion Pharmaceuticals, Inc.
 Hepion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapy for treatment of chronic liver diseases | Health Technology |
Synergy Pharmaceuticals, Inc. /Old/
Synergy Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Researches and develops drugs to treat hepatitis C, hepatitis B, epilepsy and brain cancer | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cardiff Oncology, Inc.
 Cardiff Oncology, Inc. Medical SpecialtiesHealth Technology Develops diagnostic products | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immuron Ltd.
 Immuron Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops drugs to treat gastrointestinal disorders and diseases | Health Technology |
G.D. Searle LLC | |
Synergy DE | |
University of Missouri-St. Louis
 University of Missouri-St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actavia Life Sciences, Inc.
 Actavia Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Virpax Pharmaceuticals, Inc.
 Virpax Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical-stage pharmaceutical company that develops non-addictive pain and neurological disorders | Commercial Services |
